Delos Wealth Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.6K Sell
89
-47
-35% -$19.9K 0.02% 141
2026
Q1
$64.4K Hold
136
0.04% 114
2025
Q4
$63.5K Hold
136
0.04% 82
2025
Q3
$58K Hold
136
0.04% 99
2025
Q2
$52.1K Buy
+136
New +$49K 0.04% 90
2024
Q3
Sell
-10
Closed -$3.21K 270
2024
Q2
$3.21K Hold
10
﹤0.01% 188
2024
Q1
$3.34K Buy
+10
New +$3.06K ﹤0.01% 184
2021
Q4
Sell
-15
Closed -$4K 456
2021
Q3
$4K Buy
+15
New +$3.67K ﹤0.01% 120

Other funds holding HCA

Delos Wealth Advisors's HCA Position: Q2 2026 in Review

Delos Wealth Advisors reduced its HCA Healthcare (HCA) stake by 35% in Q2 2026, selling an estimated $19.9K and leaving 89 shares worth $34.6K. The position accounts for 0.02% of the portfolio, ranked #141.

Delos Wealth Advisors first reported a position in HCA in Q3 2021 and has held it in 8 quarters since. The position peaked at $64.4K in Q1 2026. 1,339 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Delos Wealth Advisors held 89 shares of HCA Healthcare worth $34.6K as of Q2 2026.
  • Delos Wealth Advisors sold 47 HCA Healthcare shares in Q2 2026, an estimated $19.9K.
  • HCA Healthcare made up 0.02% of Delos Wealth Advisors's portfolio in Q2 2026, its #141 holding.
  • Delos Wealth Advisors first reported a position in HCA Healthcare in Q3 2021 and has held it in 8 quarters since.
  • Delos Wealth Advisors's HCA Healthcare position peaked at $64.4K in Q1 2026.
  • 1,339 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Delos Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.